Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy

Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy

SHANGHAI and HONG KONG, Dec. 2, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...

Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials

Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials

Securely connecting AI agents across multiple companies for rapid response to changing circumstances KAWASAKI, Japan, Dec. 1, 2025 /PRNewswire/ -- Fujitsu Limited today announced the development of a multi-AI agent collaboration technology that...

Imugene and JW Therapeutics Announce a Collaboration to Advance onCARlytics and Carteyva® Combination in Solid Tumours

Imugene and JW Therapeutics Announce a Collaboration to Advance onCARlytics and Carteyva® Combination in Solid Tumours

Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlytics (CF33-CD19) oncolytic virus and JW's CD19 CAR-T cell therapy, Carteyva®, in refractory solid...

RheoFit Closes Pre-A Led by Xiaohongshu (RED) and ZhenFund

RheoFit Closes Pre-A Led by Xiaohongshu (RED) and ZhenFund

SHENZHEN, China, Nov. 27, 2025 /PRNewswire/ -- On October 24, RheoFit, a consumer electronics company specializing in musculoskeletal health, announced the completion of its Pre-A funding round, led by Xiaohongshu (RED) and ZhenFund. The company...

FinFan and Thunes Forge Strategic Alliance to Strengthen Vietnam's Cross-Border Remittance Ecosystem

FinFan and Thunes Forge Strategic Alliance to Strengthen Vietnam's Cross-Border Remittance Ecosystem

SINGAPORE, Nov. 27, 2025 /PRNewswire/ -- FinFan , a Vietnam-based fintech company specializing in comprehensive cross-border remittance technology solutions, and Thunes, the Smart Superhighway to move money around the world, have signed a Memorandum...

Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics Acquisition

Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics Acquisition

The acquisition of Enci Therapeutics will advance Innova Therapeutics' lead program, IVT-8086, a humanized monoclonal antibody targeting SFRP2 which is expressed in most solid and hematological cancers. IVT-8086 is the only cancer therapeutic that...

Neurophet and The Florey Strengthen Research Collaboration on 'Neurophet AQUA' to Advance Alzheimer's Disease Diagnosis

Neurophet and The Florey Strengthen Research Collaboration on 'Neurophet AQUA' to Advance Alzheimer's Disease Diagnosis

Aiming to evaluate the utility of blood-based and other biomarkers for Alzheimer's disease diagnosis and management Joint research to enhance dementia diagnosis using the brain neurodegeneration imaging software 'Neurophet AQUA' SEOUL, South Korea,...

MOMENTUM 2025 kicks off in Riyadh on 9 December

MOMENTUM 2025 kicks off in Riyadh on 9 December

RIYADH, Saudi Arabia, Nov. 25, 2025 /PRNewswire/ -- Saudi Arabia's capital, Riyadh, will host the inaugural Development Finance Conference "MOMENTUM" from 9 to 11 December 2025 at the King Abdulaziz International Conference Center. The event is...

SmallRig and Aerial Photographer Chen Cheng Join Hands to Advance Innovation in Aerial Imaging

SmallRig and Aerial Photographer Chen Cheng Join Hands to Advance Innovation in Aerial Imaging

SHENZHEN, China, Nov. 21, 2025 /PRNewswire/ -- SmallRig, a global specialized provider of imaging solutions, has announced the acclaimed Chinese aerial photographer Chen Cheng (@superflankerstudio) as SmallRig Brand Co-Creator, marking a significant...

NovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward

NovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward

Cadmus C. Rich, MD, MBA, as Chief Medical Officer, and Carlos Quezada-Ruiz, MD, FASRS, as Chair of the Scientific Advisory Board, bring invaluable clinical development expertise to VIS-101 Program The ability to attract seasoned ophthalmology...

  • 1
  • ...
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • ...
  • 24
  • menu
    menu